Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

OPIREN FLAS 30 MG COMPRIMIDOS BUCODISPERSABLES - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/OPIREN FLAS 30 MG COMPRIMIDOS BUCODISPERSABLES

Approved

STANDARD

OPIREN FLAS 30 MG COMPRIMIDOS BUCODISPERSABLES

Takeda France S.A.S.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: May 26, 2023
Approval ID: ba4d7e33188dcf8f
Company: Takeda France S.A.S.
Type: Standard

Approval Details

Approval Id: ba4d7e33188dcf8f
Drug Cima Aemps Name: OPIREN FLAS 30 MG COMPRIMIDOS BUCODISPERSABLES
Register Number: 3400939239989IP1
Holder Company Name: Takeda France S.A.S.
Marketing Company Name: Ecofar Productos S.L.
Authorization Date: 2023-05-26
Dosage Form: COMPRIMIDO BUCODISPERSABLE
Dose: 30 mg
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: Yes
Company Name: Takeda France S.A.S.

Active Ingredients

LANSOPRAZOL

30,0 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

May 26, 2023

Approval ID

ba4d7e33188dcf8f

Type

Standard

Back to CIMA-AEMPS Approvals